Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation
Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis. Our goal was to test whether variants in the gene encoding PTX3...
Saved in:
| Published in: | American journal of respiratory and critical care medicine Vol. 186; no. 6; pp. 546 - 552 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
New York, NY
American Thoracic Society
15-09-2012
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis.
Our goal was to test whether variants in the gene encoding PTX3 are risk factors for PGD.
We performed a candidate gene association study in recipients from the multicenter, prospective Lung Transplant Outcomes Group cohort enrolled between July 2002 and July 2009. The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hours of transplantation. Targeted genotyping of 10 haplotype-tagging PTX3 single-nucleotide polymorphisms (SNPs) was performed in lung transplant recipients. The association between PGD and each SNP was evaluated by logistic regression, adjusting for pretransplantation lung disease, cardiopulmonary bypass use, and population stratification. The association between SNPs and plasma PTX3 levels was tested across genotypes in a subset of recipients with idiopathic pulmonary fibrosis.
Six hundred fifty-four lung transplant recipients were included. The incidence of PGD was 29%. Two linked 5' region variants, rs2120243 and rs2305619, were associated with PGD (odds ratio, 1.5; 95% confidence interval, 1.1 to 1.9; P = 0.006 and odds ratio, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.007, respectively). The minor allele of rs2305619 was significantly associated with higher plasma PTX3 levels measured pretransplantation (P = 0.014) and at 24 hours (P = 0.047) after transplantation in patients with idiopathic pulmonary fibrosis.
Genetic variants of PTX3 are associated with PGD after lung transplantation, and are associated with increased PTX3 plasma levels. |
|---|---|
| AbstractList | Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis.
Our goal was to test whether variants in the gene encoding PTX3 are risk factors for PGD.
We performed a candidate gene association study in recipients from the multicenter, prospective Lung Transplant Outcomes Group cohort enrolled between July 2002 and July 2009. The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hours of transplantation. Targeted genotyping of 10 haplotype-tagging PTX3 single-nucleotide polymorphisms (SNPs) was performed in lung transplant recipients. The association between PGD and each SNP was evaluated by logistic regression, adjusting for pretransplantation lung disease, cardiopulmonary bypass use, and population stratification. The association between SNPs and plasma PTX3 levels was tested across genotypes in a subset of recipients with idiopathic pulmonary fibrosis.
Six hundred fifty-four lung transplant recipients were included. The incidence of PGD was 29%. Two linked 5' region variants, rs2120243 and rs2305619, were associated with PGD (odds ratio, 1.5; 95% confidence interval, 1.1 to 1.9; P = 0.006 and odds ratio, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.007, respectively). The minor allele of rs2305619 was significantly associated with higher plasma PTX3 levels measured pretransplantation (P = 0.014) and at 24 hours (P = 0.047) after transplantation in patients with idiopathic pulmonary fibrosis.
Genetic variants of PTX3 are associated with PGD after lung transplantation, and are associated with increased PTX3 plasma levels. Rationale : Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis. Objectives : Our goal was to test whether variants in the gene encoding PTX3 are risk factors for PGD. Methods : We performed a candidate gene association study in recipients from the multicenter, prospective Lung Transplant Outcomes Group cohort enrolled between July 2002 and July 2009. The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hours of transplantation. Targeted genotyping of 10 haplotype-tagging PTX3 single-nucleotide polymorphisms (SNPs) was performed in lung transplant recipients. The association between PGD and each SNP was evaluated by logistic regression, adjusting for pretransplantation lung disease, cardiopulmonary bypass use, and population stratification. The association between SNPs and plasma PTX3 levels was tested across genotypes in a subset of recipients with idiopathic pulmonary fibrosis. Measurements and Main Results : Six hundred fifty-four lung transplant recipients were included. The incidence of PGD was 29%. Two linked 5′ region variants, rs2120243 and rs2305619, were associated with PGD (odds ratio, 1.5; 95% confidence interval, 1.1 to 1.9; P = 0.006 and odds ratio, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.007, respectively). The minor allele of rs2305619 was significantly associated with higher plasma PTX3 levels measured pretransplantation ( P = 0.014) and at 24 hours ( P = 0.047) after transplantation in patients with idiopathic pulmonary fibrosis. Conclusions : Genetic variants of PTX3 are associated with PGD after lung transplantation, and are associated with increased PTX3 plasma levels. Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis. Our goal was to test whether variants in the gene encoding PTX3 are risk factors for PGD. We performed a candidate gene association study in recipients from the multicenter, prospective Lung Transplant Outcomes Group cohort enrolled between July 2002 and July 2009. The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hours of transplantation. Targeted genotyping of 10 haplotype-tagging PTX3 single-nucleotide polymorphisms (SNPs) was performed in lung transplant recipients. The association between PGD and each SNP was evaluated by logistic regression, adjusting for pretransplantation lung disease, cardiopulmonary bypass use, and population stratification. The association between SNPs and plasma PTX3 levels was tested across genotypes in a subset of recipients with idiopathic pulmonary fibrosis. Six hundred fifty-four lung transplant recipients were included. The incidence of PGD was 29%. Two linked 5' region variants, rs2120243 and rs2305619, were associated with PGD (odds ratio, 1.5; 95% confidence interval, 1.1 to 1.9; P = 0.006 and odds ratio, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.007, respectively). The minor allele of rs2305619 was significantly associated with higher plasma PTX3 levels measured pretransplantation (P = 0.014) and at 24 hours (P = 0.047) after transplantation in patients with idiopathic pulmonary fibrosis. Genetic variants of PTX3 are associated with PGD after lung transplantation, and are associated with increased PTX3 plasma levels. RATIONALEElevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in innate immunity, mediated by PTX3 release, may play a role in PGD pathogenesis. OBJECTIVESOur goal was to test whether variants in the gene encoding PTX3 are risk factors for PGD. METHODSWe performed a candidate gene association study in recipients from the multicenter, prospective Lung Transplant Outcomes Group cohort enrolled between July 2002 and July 2009. The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD within 72 hours of transplantation. Targeted genotyping of 10 haplotype-tagging PTX3 single-nucleotide polymorphisms (SNPs) was performed in lung transplant recipients. The association between PGD and each SNP was evaluated by logistic regression, adjusting for pretransplantation lung disease, cardiopulmonary bypass use, and population stratification. The association between SNPs and plasma PTX3 levels was tested across genotypes in a subset of recipients with idiopathic pulmonary fibrosis. MEASUREMENTS AND MAIN RESULTSSix hundred fifty-four lung transplant recipients were included. The incidence of PGD was 29%. Two linked 5' region variants, rs2120243 and rs2305619, were associated with PGD (odds ratio, 1.5; 95% confidence interval, 1.1 to 1.9; P = 0.006 and odds ratio, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.007, respectively). The minor allele of rs2305619 was significantly associated with higher plasma PTX3 levels measured pretransplantation (P = 0.014) and at 24 hours (P = 0.047) after transplantation in patients with idiopathic pulmonary fibrosis. CONCLUSIONSGenetic variants of PTX3 are associated with PGD after lung transplantation, and are associated with increased PTX3 plasma levels. |
| Author | SHAHE, Rupal J ORENS, Jonathan BHORADE, Sangeeta WILES, David PALMER, Scott M LAMA, Vibha N FENG, Rui BELPERIO, John A RUSHEFSKI, Melanie CRESPO, Maria WARE, Lorraine B CHRISTIE, Jason D ARCASOY, Selim MEYER, Nuala J LEDERER, David J DIAMOND, Joshua M WEINACKER, Ann DEMISSIE, Ejigayehu SONETT, Joshua KAWUT, Steven M CANTU, Edward SHAH, Pali D WEILL, David WILLE, Keith LEE, James C |
| Author_xml | – sequence: 1 givenname: Joshua M surname: DIAMOND fullname: DIAMOND, Joshua M organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 2 givenname: Nuala J surname: MEYER fullname: MEYER, Nuala J organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 3 givenname: Sangeeta surname: BHORADE fullname: BHORADE, Sangeeta organization: Division of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois, United States – sequence: 4 givenname: Maria surname: CRESPO fullname: CRESPO, Maria organization: Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, Pennsylvania, United States – sequence: 5 givenname: Ejigayehu surname: DEMISSIE fullname: DEMISSIE, Ejigayehu organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 6 givenname: Joshua surname: SONETT fullname: SONETT, Joshua organization: Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, United States – sequence: 7 givenname: Keith surname: WILLE fullname: WILLE, Keith organization: Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States – sequence: 8 givenname: Jonathan surname: ORENS fullname: ORENS, Jonathan organization: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, Maryland, United States – sequence: 9 givenname: Ann surname: WEINACKER fullname: WEINACKER, Ann organization: Division of Pulmonary and Critical Care Medicine, Stanford University, Palo Alto, California, United States – sequence: 10 givenname: David surname: WEILL fullname: WEILL, David organization: Division of Pulmonary and Critical Care Medicine, Stanford University, Palo Alto, California, United States – sequence: 11 givenname: Selim surname: ARCASOY fullname: ARCASOY, Selim organization: Division of Pulmonary, Allergy, and Critical Care Medicine and, Columbia University College of Physicians and Surgeons, New York, New York, United States – sequence: 12 givenname: Pali D surname: SHAH fullname: SHAH, Pali D organization: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, Maryland, United States – sequence: 13 givenname: Rui surname: FENG fullname: FENG, Rui organization: Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 14 givenname: John A surname: BELPERIO fullname: BELPERIO, John A organization: Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States – sequence: 15 givenname: David surname: WILES fullname: WILES, David organization: Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States – sequence: 16 givenname: Lorraine B surname: WARE fullname: WARE, Lorraine B organization: Departments of Medicine and Pathology, Microbiology, and Immunology and, Duke University, Raleigh-Durham North Carolina, United States – sequence: 17 givenname: Scott M surname: PALMER fullname: PALMER, Scott M organization: Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Raleigh-Durham North Carolina, United States – sequence: 18 givenname: Jason D surname: CHRISTIE fullname: CHRISTIE, Jason D organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 19 givenname: Melanie surname: RUSHEFSKI fullname: RUSHEFSKI, Melanie organization: Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 20 givenname: David J surname: LEDERER fullname: LEDERER, David J organization: Division of Pulmonary, Allergy, and Critical Care Medicine and, Columbia University College of Physicians and Surgeons, New York, New York, United States – sequence: 21 givenname: Steven M surname: KAWUT fullname: KAWUT, Steven M organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 22 givenname: James C surname: LEE fullname: LEE, James C organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 23 givenname: Edward surname: CANTU fullname: CANTU, Edward organization: Division of Cardiovascular Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 24 givenname: Rupal J surname: SHAHE fullname: SHAHE, Rupal J organization: Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States – sequence: 25 givenname: Vibha N surname: LAMA fullname: LAMA, Vibha N organization: Division of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26399395$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22822025$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkV1vFCEUhompsR_6B7wwJMbEm6kcYBi4MWnWWpts0l6spl4RhoWWZhZWmLHpv5d21vpxBRye8-a85z1EezFFh9BrIMcAgn_I1m6OKQFKeEOEoheLZ-gAWtY2XHVkr95JxxrO1dU-OizlllRUAnmB9imVlBLaHqDv30wOZgwp4hDx5eqK4fOCT0pJtpbdGt-F8QZf5rAx-R6fZeNH_Om--Cnax6b6dhkvp3iNV9nEsh1MHB_1XqLn3gzFvdqdR-jr59PV4kuzvDg7X5wsG8tBjI2yxHnBevCyt0CE6RjvoV-bzrbUSiFo56TtmFI9GE9ZRylVxktDpfVeSXaEPs6626nfuLV1ccxm0Nt5ZJ1M0P_-xHCjr9NPzbgkLaNV4P1OIKcfkyuj3oRi3VCduDQVDdACYUxRqOjb_9DbNOVY7WkgreyAi5ZXis6UzamU7PzTMED0Q3L6ITk9J6fn5GrTm79tPLX8jqoC73aAKdYMvm7bhvKHE3VFTLXsFzTNpJk |
| CitedBy_id | crossref_primary_10_1164_rccm_201207_1158ED crossref_primary_10_18632_oncotarget_23902 crossref_primary_10_1016_j_jtcvs_2014_09_077 crossref_primary_10_1111_ajt_13525 crossref_primary_10_1086_675988 crossref_primary_10_1097_MOT_0000000000000236 crossref_primary_10_1111_ajt_13964 crossref_primary_10_1513_AnnalsATS_201610_810OC crossref_primary_10_1097_MOT_0000000000000232 crossref_primary_10_1172_jci_insight_173716 crossref_primary_10_1164_rccm_202303_0472OC crossref_primary_10_1371_journal_pone_0053030 crossref_primary_10_1016_j_ajt_2022_11_017 crossref_primary_10_1164_rccm_202112_2771OC crossref_primary_10_1097_MOT_0b013e3283651994 crossref_primary_10_1513_AnnalsATS_201311_388OC crossref_primary_10_3389_fimmu_2020_622772 crossref_primary_10_1093_cvr_cvz068 crossref_primary_10_1056_NEJMoa1211161 crossref_primary_10_1111_ctr_13219 crossref_primary_10_1177_1089253219881980 crossref_primary_10_3389_fonc_2019_00581 crossref_primary_10_1111_ajt_12428 crossref_primary_10_1111_ajt_14209 crossref_primary_10_12659_MSM_902783 crossref_primary_10_23736_S0375_9393_18_12651_4 crossref_primary_10_1164_rccm_201307_1283OC crossref_primary_10_1016_j_pharmthera_2021_107993 crossref_primary_10_1016_j_matbio_2018_01_027 crossref_primary_10_1053_j_jvca_2013_02_021 crossref_primary_10_1080_17476348_2017_1280398 crossref_primary_10_1172_jci_insight_164603 crossref_primary_10_1016_j_genrep_2020_100670 crossref_primary_10_1016_j_healun_2015_03_009 crossref_primary_10_1002_eji_201847811 crossref_primary_10_1016_j_healun_2017_07_020 crossref_primary_10_1097_TP_0000000000004503 crossref_primary_10_1055_s_0041_1728794 crossref_primary_10_1051_ject_201345016 crossref_primary_10_1186_s43162_021_00049_w crossref_primary_10_1038_s41598_023_36143_y crossref_primary_10_1111_tri_13749 crossref_primary_10_1172_jci_insight_133083 crossref_primary_10_1016_j_ajt_2023_01_020 crossref_primary_10_1186_s13054_014_0562_5 crossref_primary_10_1016_j_ccm_2017_07_005 crossref_primary_10_1136_thoraxjnl_2020_215356 crossref_primary_10_1172_jci_insight_138358 crossref_primary_10_1111_cei_12957 crossref_primary_10_1016_j_healun_2019_08_013 crossref_primary_10_1111_ctr_13678 crossref_primary_10_1152_physrev_00016_2017 crossref_primary_10_1016_j_ccm_2017_07_009 crossref_primary_10_1146_annurev_med_080119_103200 crossref_primary_10_1111_jvh_12472 crossref_primary_10_5320_wjr_v3_i3_77 |
| Cites_doi | 10.1378/chest.124.4.1232 10.1371/journal.pone.0028268 10.1164/rccm.200901-0118OC 10.1016/j.transproceed.2007.07.056 10.4049/jimmunol.150.5.1804 10.1016/j.healun.2005.03.004 10.1016/j.healun.2004.11.314 10.1164/rccm.200606-827OC 10.1056/NEJMoa1014597 10.1164/rccm.200408-1129OC 10.1111/j.1600-6143.2010.03431.x 10.1161/CIRCULATIONAHA.105.000901 10.1126/science.1069424 10.1016/S0021-9258(18)41653-5 10.1371/journal.pone.0003583 10.1016/j.semarthrit.2008.03.006 10.1093/bioinformatics/bth457 10.1007/s00134-010-2067-2 10.1073/pnas.0704828104 10.1074/jbc.M110.108001 10.1111/j.1600-6143.2007.01669.x 10.1164/rccm.200409-1243OC 10.1056/NEJM198803243181202 10.1097/CCM.0b013e3181809aaf 10.1152/ajplung.00490.2006 10.1093/hmg/ddr377 10.1161/01.CIR.97.22.2259 10.1097/MOT.0b013e32833e1415 10.1016/j.jinf.2009.04.004 10.1146/annurev.immunol.23.021704.115756 10.1038/nature09534 10.1371/journal.pone.0001318 10.1097/00003246-200107000-00017 10.1172/JCI6709 10.1111/j.1600-6143.2011.03702.x 10.1016/j.healun.2004.11.049 10.1007/s00134-009-1720-0 10.1164/rccm.200303-447OC 10.4049/jimmunol.1003052 10.1016/S0264-410X(03)00199-3 10.1038/sj.gene.6364410 10.1097/TP.0b013e31819064b8 10.1161/01.CIR.0000112575.66565.84 10.4049/jimmunol.180.10.6954 10.1371/journal.pgen.1000562 10.1016/j.healun.2010.05.013 10.1159/000329492 10.1016/j.healun.2009.12.013 10.1161/01.RES.82.11.1224 10.1074/jbc.272.13.8172 10.1086/519795 10.1038/gene.2010.41 10.1038/nature02168 |
| ContentType | Journal Article |
| Copyright | 2015 INIST-CNRS Copyright American Thoracic Society Sep 15, 2012 Copyright © 2012 by the American Thoracic Society 2012 |
| Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright American Thoracic Society Sep 15, 2012 – notice: Copyright © 2012 by the American Thoracic Society 2012 |
| CorporateAuthor | Lung Transplant Outcomes Group for the Lung Transplant Outcomes Group |
| CorporateAuthor_xml | – name: Lung Transplant Outcomes Group – name: for the Lung Transplant Outcomes Group |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1164/rccm.201204-0692OC |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Public Health MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1535-4970 |
| EndPage | 552 |
| ExternalDocumentID | 2768369811 10_1164_rccm_201204_0692OC 22822025 26399395 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K23 HL102254 – fundername: NHLBI NIH HHS grantid: R01 HL087115 – fundername: NHLBI NIH HHS grantid: L30 HL097857 – fundername: NHLBI NIH HHS grantid: K24 HL103836 – fundername: NHLBI NIH HHS grantid: K23 HL116656 – fundername: NHLBI NIH HHS grantid: R01 HL096845 – fundername: NHLBI NIH HHS grantid: K24 HL103844 – fundername: NHLBI NIH HHS grantid: T32 HL007891 – fundername: NHLBI NIH HHS grantid: R01 HL081619 |
| GroupedDBID | --- -~X .55 .GJ 08R 0R~ 1CY 1KJ 23M 2WC 34G 39C 3O- 3V. 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAEJM AAQQT AAUGY AAWTL ABOCM ABPMR ABUWG ACBNA ACGFO ACGFS ACRZS ADBBV AENEX AFCHL AFFNX AFKRA AFUWQ AHMBA AI. AJJEV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 H13 HZ~ IH2 IQODW J5H KQ8 L7B M1P M5~ N4W NAPCQ O9- OBH OFXIZ OGEVE OHT OK1 OVD OVIDX P2P PCD PQQKQ PROAC PSQYO Q2X RPM RWL SJN TAE TEORI THO TR2 UKHRP VH1 W8F WH7 WOQ WOW X7M YCJ YJK ZA5 ZE2 ZGI ZXP ~02 ABJNI ALIPV CGR CUY CVF ECM EIF HMCUK NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c416t-9c0ef63b1f8bc106a734b1bda7c52c86627e8c7399b1af2372229af8a28cff983 |
| ISSN | 1073-449X |
| IngestDate | Tue Sep 17 21:26:03 EDT 2024 Wed Jul 24 17:52:37 EDT 2024 Thu Oct 10 18:23:18 EDT 2024 Fri Aug 23 00:17:13 EDT 2024 Sat Sep 28 07:52:27 EDT 2024 Sun Oct 22 16:08:30 EDT 2023 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Intensive care long pentraxin 3 lung transplantation Single nucleotide polymorphism Graft primary dysfunction single-nucleotide polymorphism Resuscitation primary graft dysfunction |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c416t-9c0ef63b1f8bc106a734b1bda7c52c86627e8c7399b1af2372229af8a28cff983 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 22822025 |
| PQID | 1058714654 |
| PQPubID | 40575 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480532 proquest_miscellaneous_1151033921 proquest_journals_1058714654 crossref_primary_10_1164_rccm_201204_0692OC pubmed_primary_22822025 pascalfrancis_primary_26399395 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-09-15 |
| PublicationDateYYYYMMDD | 2012-09-15 |
| PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
| PublicationTitle | American journal of respiratory and critical care medicine |
| PublicationTitleAlternate | Am J Respir Crit Care Med |
| PublicationYear | 2012 |
| Publisher | American Thoracic Society |
| Publisher_xml | – name: American Thoracic Society |
| References | 15771574 - Annu Rev Immunol. 2005;23:337-66 17277044 - Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1039-49 17701901 - Am J Hum Genet. 2007 Sep;81(3):559-75 22984023 - Am J Respir Crit Care Med. 2012 Sep 15;186(6):475-7 14685227 - Nature. 2003 Dec 18;426(6968):789-96 19609346 - PLoS Genet. 2009 Jul;5(7):e1000562 16210116 - J Heart Lung Transplant. 2005 Oct;24(10):1454-9 21149598 - J Immunol. 2011 Jan 15;186(2):1044-59 21883907 - Am J Transplant. 2011 Nov;11(11):2517-22 9633921 - Circ Res. 1998 Jun 15;82(11):1224-30 20981092 - Nature. 2010 Oct 28;467(7319):1061-73 20927127 - Genes Immun. 2010 Dec;11(8):665-70 18596636 - Crit Care Med. 2008 Aug;36(8):2302-8 16210119 - J Heart Lung Transplant. 2005 Oct;24(10):1483-8 12773319 - Am J Respir Crit Care Med. 2003 Sep 15;168(6):628-32 17889209 - Transplant Proc. 2007 Sep;39(7):2425-6 12763682 - Vaccine. 2003 Jun 1;21 Suppl 2:S43-7 12029063 - Science. 2002 Jun 21;296(5576):2225-9 21968286 - J Innate Immun. 2012;4(2):168-75 14970116 - Circulation. 2004 Feb 17;109(6):784-9 18974833 - PLoS One. 2008;3(10):e3583 21865300 - Hum Mol Genet. 2011 Nov 15;20(22):4462-74 20655249 - J Heart Lung Transplant. 2010 Nov;29(11):1231-9 15297300 - Bioinformatics. 2005 Jan 15;21(2):263-5 16210115 - J Heart Lung Transplant. 2005 Oct;24(10):1451-3 17023732 - Am J Respir Crit Care Med. 2007 Jan 1;175(1):69-74 20693898 - Curr Opin Organ Transplant. 2010 Oct;15(5):552-7 18614204 - Semin Arthritis Rheum. 2009 Aug;39(1):38-54 19661249 - Am J Respir Crit Care Med. 2009 Nov 15;180(10):1010-5 21488765 - N Engl J Med. 2011 Apr 14;364(15):1431-40 21072499 - Intensive Care Med. 2011 Feb;37(2):334-42 19443038 - J Infect. 2009 Jun;58(6):425-32 9079634 - J Biol Chem. 1997 Mar 28;272(13):8172-8 7679696 - J Immunol. 1993 Mar 1;150(5):1804-12 17611589 - Genes Immun. 2007 Sep;8(6):456-67 9631876 - Circulation. 1998 Jun 9;97(22):2259-67 20227302 - J Heart Lung Transplant. 2010 Jun;29(6):665-71 22295056 - PLoS One. 2012;7(1):e28268 21138842 - J Biol Chem. 2011 Feb 18;286(7):5727-35 16820585 - Circulation. 2006 Jul 4;114(1 Suppl):I270-4 19921147 - Intensive Care Med. 2010 Feb;36(2):356-64 1429570 - J Biol Chem. 1992 Nov 5;267(31):22190-7 21299834 - Am J Transplant. 2011 Mar;11(3):561-7 19104434 - Transplantation. 2008 Dec 27;86(12):1857-63 15640363 - Am J Respir Crit Care Med. 2005 Apr 1;171(7):780-5 10430608 - J Clin Invest. 1999 Aug;104(3):271-80 11445697 - Crit Care Med. 2001 Jul;29(7):1404-7 17217435 - Am J Transplant. 2007 Mar;7(3):693-9 18091991 - PLoS One. 2007;2(12):e1318 14555551 - Chest. 2003 Oct;124(4):1232-41 3347221 - N Engl J Med. 1988 Mar 24;318(12):727-32 15764726 - Am J Respir Crit Care Med. 2005 Jun 1;171(11):1312-6 18453617 - J Immunol. 2008 May 15;180(10):6954-61 17925445 - Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16645-50 bib36 bib37 bib34 bib35 bib32 bib33 bib30 bib31 Diamond JM (bib26) 2011; 30 bib29 bib27 bib28 bib40 bib47 bib48 bib45 bib46 bib43 bib44 bib41 bib42 bib9 bib7 bib8 bib5 bib6 bib3 bib38 bib4 bib39 bib1 bib2 bib50 bib51 bib14 bib15 bib12 bib13 bib10 bib54 bib11 bib52 bib53 bib49 Lee GW (bib16) 1993; 150 bib25 bib23 bib24 bib21 bib22 bib20 bib18 bib19 bib17 |
| References_xml | – ident: bib3 doi: 10.1378/chest.124.4.1232 – ident: bib36 doi: 10.1371/journal.pone.0028268 – ident: bib29 doi: 10.1164/rccm.200901-0118OC – ident: bib6 doi: 10.1016/j.transproceed.2007.07.056 – volume: 150 start-page: 1804 year: 1993 ident: bib16 publication-title: J Immunol doi: 10.4049/jimmunol.150.5.1804 contributor: fullname: Lee GW – ident: bib31 doi: 10.1016/j.healun.2005.03.004 – ident: bib1 doi: 10.1016/j.healun.2004.11.314 – ident: bib28 doi: 10.1164/rccm.200606-827OC – ident: bib39 doi: 10.1056/NEJMoa1014597 – ident: bib43 doi: 10.1164/rccm.200408-1129OC – ident: bib4 doi: 10.1111/j.1600-6143.2010.03431.x – ident: bib49 doi: 10.1161/CIRCULATIONAHA.105.000901 – ident: bib38 doi: 10.1126/science.1069424 – ident: bib15 doi: 10.1016/S0021-9258(18)41653-5 – ident: bib34 doi: 10.1371/journal.pone.0003583 – ident: bib18 doi: 10.1016/j.semarthrit.2008.03.006 – ident: bib37 doi: 10.1093/bioinformatics/bth457 – ident: bib19 doi: 10.1007/s00134-010-2067-2 – ident: bib51 doi: 10.1073/pnas.0704828104 – ident: bib48 doi: 10.1074/jbc.M110.108001 – ident: bib44 doi: 10.1111/j.1600-6143.2007.01669.x – volume: 30 start-page: S23 year: 2011 ident: bib26 publication-title: J Heart Lung Transplant contributor: fullname: Diamond JM – ident: bib2 doi: 10.1164/rccm.200409-1243OC – ident: bib12 doi: 10.1056/NEJM198803243181202 – ident: bib22 doi: 10.1097/CCM.0b013e3181809aaf – ident: bib21 doi: 10.1152/ajplung.00490.2006 – ident: bib54 doi: 10.1093/hmg/ddr377 – ident: bib10 doi: 10.1161/01.CIR.97.22.2259 – ident: bib5 doi: 10.1097/MOT.0b013e32833e1415 – ident: bib24 doi: 10.1016/j.jinf.2009.04.004 – ident: bib13 doi: 10.1146/annurev.immunol.23.021704.115756 – ident: bib32 doi: 10.1038/nature09534 – ident: bib52 doi: 10.1371/journal.pone.0001318 – ident: bib23 doi: 10.1097/00003246-200107000-00017 – ident: bib7 doi: 10.1172/JCI6709 – ident: bib14 doi: 10.1111/j.1600-6143.2011.03702.x – ident: bib30 doi: 10.1016/j.healun.2004.11.049 – ident: bib20 doi: 10.1007/s00134-009-1720-0 – ident: bib42 doi: 10.1164/rccm.200303-447OC – ident: bib47 doi: 10.4049/jimmunol.1003052 – ident: bib17 doi: 10.1016/S0264-410X(03)00199-3 – ident: bib46 doi: 10.1038/sj.gene.6364410 – ident: bib41 doi: 10.1097/TP.0b013e31819064b8 – ident: bib8 doi: 10.1161/01.CIR.0000112575.66565.84 – ident: bib9 doi: 10.4049/jimmunol.180.10.6954 – ident: bib50 doi: 10.1371/journal.pgen.1000562 – ident: bib27 doi: 10.1016/j.healun.2010.05.013 – ident: bib53 doi: 10.1159/000329492 – ident: bib40 doi: 10.1016/j.healun.2009.12.013 – ident: bib11 doi: 10.1161/01.RES.82.11.1224 – ident: bib25 doi: 10.1074/jbc.272.13.8172 – ident: bib35 doi: 10.1086/519795 – ident: bib45 doi: 10.1038/gene.2010.41 – ident: bib33 doi: 10.1038/nature02168 |
| SSID | ssj0012810 |
| Score | 2.3846157 |
| Snippet | Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation. Abnormalities in... RATIONALEElevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation.... Rationale : Elevated long pentraxin-3 (PTX3) levels are associated with the development of primary graft dysfunction (PGD) after lung transplantation.... |
| SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 546 |
| SubjectTerms | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction C-Reactive Protein - genetics C-Reactive Protein - metabolism Cohort Studies Confidence Intervals Female Follow-Up Studies Genetic Association Studies Genotype Graft Rejection - epidemiology Graft Rejection - genetics Graft Survival Haplotypes Health risk assessment Humans Idiopathic Pulmonary Fibrosis - diagnosis Idiopathic Pulmonary Fibrosis - surgery Incidence Intensive care medicine Ischemia Logistic Models Lung diseases Lung Transplantation - adverse effects Lung Transplantation - methods Lung transplants Male Medical sciences Middle Aged Odds Ratio Patients Plasma Polymorphism, Single Nucleotide Primary Graft Dysfunction - genetics Primary Graft Dysfunction - pathology Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - surgery Pulmonary fibrosis Regression analysis Retrospective Studies Risk Assessment Serum Amyloid P-Component - genetics Serum Amyloid P-Component - metabolism Severity of Illness Index Statistical analysis Statistics, Nonparametric Time Factors Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
| Title | Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22822025 https://www.proquest.com/docview/1058714654 https://search.proquest.com/docview/1151033921 https://pubmed.ncbi.nlm.nih.gov/PMC3480532 |
| Volume | 186 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lRUJICPEsgVItErfI4MfaXh8RSVVEExCkKJys9T5IpMiN4vjQf8-MvXbslEM5cFlFa2ejzHxez-w8PkLegY0geSiEw0wMg1KRk3CunFj5UkaGuVJh7fDFj3i24OMJmwwGDWvGfu6_ahrmQNdYOfsP2m4XhQn4DDqHEbQO4530_hOcX9FkMH6bLwKkLBdWCU2u-cb2mPi9FWY3UjcFvt46nOHrsmaPyIvNWuSdaH3Tr7aJ83QaT2w7QfuqWK4hUaiSyw5j-OMV0hwpG4RYlmJ_LDvVNzWOZqVYi1HnyLvel76XqzZMVBZLbSz19lSvsV6-e46BCSGJU1dyvtfN3hsi4Z3b35yjDgq7W21ojy7rt3ZY98G9_UKIGGhsKyV2HfB8TLmJEt_2y-x13559Tc-vLi_T-WQxPyL3fNi4MEV0_PlLG5Xyuec2hVcR-3B71Z5x83AjCpCyqQlS_ubBHCbidiyb-WPyyLok9GONpSdkoPOn5P7UKuwZ-dVCiq5yipCiq4LuIUURUtRCilaQoh1I0QpSFCFFDyD1nFydT-afLhzLyOFIMNx3TiJdbaIg8wzPpOdGIg5Y5mVKxDL0JUcyAc1lDEZv5gnjBzGyxQvDhc-lMQkPXpDj_DrXLwnloat5pLXvRoqFBvxmoX3DA6aygDETDsmoEWVq_0FaOawRS1HwaS34tBb8kJz1pN1-xa8s8ASWO23En9pHo4D1Qh572FFwSN62l2F_xaCZyPV1Cfd42HMSvAhvSE5qbe0XxxxscBqGJO7psb0Be7f3r-SrZdXDPWAcOVle3eF3X5MH--fllBzvtqV-Q44KVZ5V8PwDGGy9Ow |
| link.rule.ids | 230,315,782,786,887,27935,27936 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variation+in+PTX3+is+associated+with+primary+graft+dysfunction+after+lung+transplantation&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Diamond%2C+Joshua+M&rft.au=Meyer%2C+Nuala+J&rft.au=Feng%2C+Rui&rft.au=Rushefski%2C+Melanie&rft.date=2012-09-15&rft.eissn=1535-4970&rft.volume=186&rft.issue=6&rft.spage=546&rft.epage=552&rft_id=info:doi/10.1164%2Frccm.201204-0692OC&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |